Jennison Associates’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
771,522
-80,602
| -9% | -$1.19M | 0.01% | 370 |
|
|
2025
Q1 | $15.3M | Buy |
852,124
+35,725
| +4% | +$640K | 0.01% | 353 |
|
|
2024
Q4 | $14.2M | Buy |
+816,399
| New | +$14.2M | 0.01% | 369 |
|
|
2019
Q2 | – | Sell |
-590,390
| Closed | -$13.4M | – | 675 |
|
|
2019
Q1 | $13.4M | Sell |
590,390
-114
| -0% | -$2.58K | 0.01% | 408 |
|
|
2018
Q4 | $13.4M | Sell |
590,504
-203,815
| -26% | -$4.61M | 0.01% | 405 |
|
|
2018
Q3 | $22.8M | Sell |
794,319
-276,008
| -26% | -$7.93M | 0.02% | 375 |
|
|
2018
Q2 | $29.2M | Buy |
1,070,327
+14,166
| +1% | +$386K | 0.03% | 346 |
|
|
2018
Q1 | $23.6M | Buy |
1,056,161
+93,365
| +10% | +$2.09M | 0.02% | 369 |
|
|
2017
Q4 | $20.3M | Sell |
962,796
-432,665
| -31% | -$9.12M | 0.02% | 403 |
|
|
2017
Q3 | $34.7M | Sell |
1,395,461
-302,464
| -18% | -$7.53M | 0.04% | 321 |
|
|
2017
Q2 | $32.9M | Sell |
1,697,925
-140,872
| -8% | -$2.73M | 0.03% | 324 |
|
|
2017
Q1 | $33.9M | Sell |
1,838,797
-287,097
| -14% | -$5.3M | 0.04% | 333 |
|
|
2016
Q4 | $40.2M | Buy |
2,125,894
+2,407
| +0.1% | +$45.6K | 0.04% | 300 |
|
|
2016
Q3 | $47.5M | Sell |
2,123,487
-140,788
| -6% | -$3.15M | 0.05% | 286 |
|
|
2016
Q2 | $40.3M | Sell |
2,264,275
-833
| -0% | -$14.8K | 0.04% | 316 |
|
|
2016
Q1 | $30.9M | Sell |
2,265,108
-78,551
| -3% | -$1.07M | 0.03% | 355 |
|
|
2015
Q4 | $45.2M | Buy |
2,343,659
+66,299
| +3% | +$1.28M | 0.04% | 299 |
|
|
2015
Q3 | $46.1M | Sell |
2,277,360
-690,143
| -23% | -$14M | 0.05% | 314 |
|
|
2015
Q2 | $98.4M | Sell |
2,967,503
-276,384
| -9% | -$9.16M | 0.09% | 205 |
|
|
2015
Q1 | $77.7M | Buy |
3,243,887
+96,594
| +3% | +$2.31M | 0.07% | 250 |
|
|
2014
Q4 | $38.5M | Sell |
3,147,293
-54,650
| -2% | -$669K | 0.04% | 366 |
|
|
2014
Q3 | $28.9M | Buy |
3,201,943
+473
| +0% | +$4.27K | 0.03% | 407 |
|
|
2014
Q2 | $37.6M | Buy |
3,201,470
+1,231,651
| +63% | +$14.5M | 0.03% | 364 |
|
|
2014
Q1 | $41.9M | Buy |
+1,969,819
| New | +$41.9M | 0.04% | 351 |
|